These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8930492)

  • 1. Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally.
    Boehncke WH; Gall H
    Contact Dermatitis; 1996 Sep; 35(3):187-8. PubMed ID: 8930492
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an objective method of determining skin erythema to transdermal oestradiol patches.
    Ross D; Whitehead M; Pike B
    Br J Obstet Gynaecol; 1999 Mar; 106(3):279-83. PubMed ID: 10426650
    [No Abstract]   [Full Text] [Related]  

  • 4. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 6. Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo.
    Murkes D; Lalitkumar PG; Leifland K; Lundström E; Söderqvist G
    Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():12-5. PubMed ID: 22834417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pruritus during treatment with an estrogen-gestagen combination].
    Siepmann M; Kirch W
    Dtsch Med Wochenschr; 2000 May; 125(18):557-9. PubMed ID: 10835981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HRT and long-term compliance: the efficacy and safety of Menorest.
    Studd J; Panay N; Zamblera D; Leather AT
    Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S21-5. PubMed ID: 8666123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin reactions with transdermal estradiol therapy in a tropical environment.
    Bhathena RK; Anklesaria BS; Ganatra AM
    Int J Gynaecol Obstet; 1998 Feb; 60(2):177-9. PubMed ID: 9509960
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous reactions to vitamin K.
    Sanders MN; Winkelmann RK
    J Am Acad Dermatol; 1988 Oct; 19(4):699-704. PubMed ID: 2972759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and C-reactive protein: does an alternate route lead to a more attractive destination?
    Duvernoy C
    Thromb Haemost; 2003 Jul; 90(1):1-2. PubMed ID: 12876618
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomised crossover comparison of skin irritation with two transdermal oestradiol patches.
    Ross D; Rees M; Godfree V; Cooper A; Hart D; Kingsland C; Whitehead M
    BMJ; 1997 Aug; 315(7103):288. PubMed ID: 9274549
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen replacement therapy on thrombin generation.
    Pinto S; Bruni V; Rosati D; Prisco D; Costanzo M; Giusti B; Abbate R
    Thromb Res; 1997 Feb; 85(3):185-93. PubMed ID: 9058493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
    Winkler UH; Krämer R; Kwee B; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical effectiveness of a new matrix plaster: an overview].
    Schindler AE; Schindler EM
    Zentralbl Gynakol; 1995; 117(10):508-9. PubMed ID: 7491832
    [No Abstract]   [Full Text] [Related]  

  • 18. Menorest: a clinical overview.
    Wren B
    Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S27-9. PubMed ID: 8666124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone substitution treatment of the menopause].
    González-Merlo J; Castelo-Branco C; Celades M
    Rev Med Univ Navarra; 1992; 37(3):143-51. PubMed ID: 1336213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.